COMMUNIQUÉS West-GlobeNewswire

Revive Therapeutics Announces Results for the Three and Six Months Ended December 31, 2017
28/02/2018
TORONTO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the " Company ") (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel [...]
Endocyte Announces Proposed Public Offering of Common Stock
28/02/2018
WEST LAFAYETTE, Ind., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, announced today that it intends to [...]
Important progress on pharmacare cannot be delayed by more studies: CFNU
28/02/2018
OTTAWA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Canada’s nurses applaud the announcement in today’s federal budget of an Advisory Council on the Implementation of National Pharmacare, chaired by Dr. Eric Hoskins, with a [...]
Radient Technologies Inc. Releases Q3 2018 Results
28/02/2018
EDMONTON, Alberta , Feb. 27, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the "Company") (TSX Venture:RTI) announced today that it has released its third quarter financial results for the fiscal year [...]
BeiGene Announces Approval of REVLIMID® for Newly Diagnosed Multiple Myeloma in China
28/02/2018
BEIJING, China, and CAMBRIDGE, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]
R1 RCM to Release Fourth Quarter 2017 Results on March 9
27/02/2018
CHICAGO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it expects to release [...]
Amedisys Reports Fourth Quarter and Year End 2017 Financial Results
27/02/2018
BATON ROUGE, La., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ) today reported its financial results for the three month period and year ended December 31, 2017. Three Month Periods Ended December 31 [...]
Mesoblast Operational Highlights and Financial Results for the Half-Year Ended December 31, 2017
27/02/2018
MELBOURNE, Australia and NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq: MESO ) today provided the market with an update on its operational highlights and consolidated financial results [...]
Burcon Announces Receipt of Nasdaq Letter Regarding Deficiency in Compliance With Certain Listing Rules
27/02/2018
VANCOUVER, British Columbia, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Company”), a leader in natural product extraction, purification and isolation [...]
Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results
27/02/2018
SAN DIEGO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX ), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial results for the three [...]
Lexicon Pharmaceuticals to Present at Upcoming Investor Conferences
27/02/2018
THE WOODLANDS, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ) today announced that Jeffrey L. Wade, J.D., Executive Vice President, Corporate and Administrative Affairs and Chief [...]
Atrion Reports 2017 Results for Fourth Quarter and Full Year
27/02/2018
ALLEN, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI ) announced today that for the fourth quarter of 2017 revenues were $34.0 million compared to $33.3 million in the same period of 2016, [...]
Capital Senior Living Corporation Reports Fourth Quarter and Full Year 2017 Results
27/02/2018
DALLAS, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU ), one of the nation’s largest operators of senior housing communities, today announced operating and financial [...]
Reata Provides Program Update on Phase 2 Rare Renal Clinical Trials
27/02/2018
First patient enrolled for all cohorts of PHOENIX First data from PHOENIX expected 2H18 Retained benefit analysis from Phase 2 portion of CARDINAL expected 3Q18 IRVING, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Reata [...]
Supernus Announces Record Full Year 2017 Financial Results, Exceeding Operating Earnings Guidance
27/02/2018
Fourth quarter 2017 total revenue of $88.4 million, a 42% increase over 2016, and fourth quarter 2017 net product sales of $86.3 million, a 41% increase over 2016. Fourth quarter 2017 operating earnings of $34.3 million [...]
FibroGen Reports Fourth Quarter and Full Year 2017 Financial Results
27/02/2018
Roxadustat U.S. Phase 3 Program in CKD Anemia Enrollment Completion and Data Readout in 2018 Pamrevlumab Phase 2 IPF Study Achieves Statistically Significant Attenuation of Lung Fibrosis as Measured by Quantitative HRCT [...]
GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2017 Financial Results
27/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today reported recent business progress and financial results for the fourth quarter and year ended [...]
K2M Group Holdings, Inc. to Participate in Four Investor Conferences in March
27/02/2018
LEESBURG, Va., Feb. 27, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]
Humanigen Completes Exchange of Loan Obligations for Equity
27/02/2018
Company Transformation Continues, Focused on Making CAR-T Safer, Better, More Routine Lenzilumab Nears Start of Clinical Testing to Prevent Critical CAR-T-related Neurotoxicity BRISBANE, Calif., Feb. 27, 2018 (GLOBE [...]

Pages